Showing results (11-20 of 82) with videos related to
Sort By:
Pageof 9
Acta Neurologica Scandinavica|December 1, 1981
Decreased cell-mediated immunity to respiratory syncytial virus in multiple sclerosisV Schauf, C L Schauf, M Mizen, et al.Annals of Neurology|January 1, 1987
4-Aminopyridine improves clinical signs in multiple sclerosisD Stefoski, F A Davis, M Faut, et al.Experientia|February 15, 1987
Selective blockade of components of potassium activation in Myxicola axonsM A Chuman, C L Schauf, F A Davis, et al.Neurology|May 1, 1978
Complement-dependent serum: neuroelectric blocking activity in multiple sclerosisC L Schauf, V Schauf, F A Davis, et al.The Journal of Pharmacology and Experimental Therapeutics|May 1, 1976
Aminopyridines and sparteine as inhibitors of membrane potassium conductance: effects on Myxicola giant axons and the lobster neuromuscular junctionC L Schauf, C A Colton, J S Colton, et al.Journal of Neurology, Neurosurgery, and Psychiatry|May 1, 1976
Experimental studies of the effects of extrinsic factors on conduction in normal and demyelinated nerve. 1. TemperatureF A Davis, C L Schauf, B J Reed, et al.Neurology|September 1, 1977
Lymphocyte subpopulations in multiple scerlosis: comparison with neuroelectric blocking activityC L Schauf, V Schauf, F A Davis, et al.Neurology|August 1, 1982
Plasmapheresis decreases neuroelectric blocking activity in multiple sclerosisD Stefoski, C L Schauf, B C McLeod, et al.Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 1976
Neuroelectric blocking factors in human and animal sera evaluated using the isolated frog spinal cordC L Schauf, F A Davis, D A Sack, et al.Neurology|September 1, 1980
Neuroelectric blocking activity and plasmapheresis in amyotrophic lateral sclerosisC L Schauf, J P Antel, B G Arnason, et al.Pageof 9